The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Transdermal Patch-Global Market Insights and Sales Trends 2025

Transdermal Patch-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1816911

No of Pages : 110

Ask Your Query
Synopsis
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
The global Transdermal Patch market size is expected to reach US$ 8726.9 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Transdermal Patch in various end use industries. The expanding demands from the Rx Channel and OTC Channel, are propelling Transdermal Patch market. Methyl Salicylate-based Patch, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rivastigmine Transdermal Patch segment is estimated at % CAGR for the next seven-year period.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transdermal Patch market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transdermal Patch market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transdermal Patch sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transdermal Patch covered in this report include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal and IBSA Group, etc.
The global Transdermal Patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Global Transdermal Patch market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transdermal Patch market, Segment by Type:
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Global Transdermal Patch market, by Application
Rx Channel
OTC Channel
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Transdermal Patch Market Overview
1.1 Transdermal Patch Product Overview
1.2 Transdermal Patch Market Segment by Type
1.2.1 Methyl Salicylate-based Patch
1.2.2 Rivastigmine Transdermal Patch
1.2.3 Fentanyl Transdermal Patch
1.2.4 Lidocaine Patch
1.2.5 Diclofenac Patch
1.2.6 Nicotine Transdermal Patch
1.2.7 Others
1.3 Global Transdermal Patch Market Size by Type
1.3.1 Global Transdermal Patch Market Size Overview by Type (2018-2029)
1.3.2 Global Transdermal Patch Historic Market Size Review by Type (2018-2023)
1.3.3 Global Transdermal Patch Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Patch Sales Breakdown by Type (2018-2023)
1.4.2 Europe Transdermal Patch Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Transdermal Patch Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Transdermal Patch Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Transdermal Patch Sales Breakdown by Type (2018-2023)
2 Global Transdermal Patch Market Competition by Company
2.1 Global Top Players by Transdermal Patch Sales (2018-2023)
2.2 Global Top Players by Transdermal Patch Revenue (2018-2023)
2.3 Global Top Players by Transdermal Patch Price (2018-2023)
2.4 Global Top Manufacturers Transdermal Patch Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Patch Market Competitive Situation and Trends
2.5.1 Transdermal Patch Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Patch Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patch as of 2022)
2.7 Date of Key Manufacturers Enter into Transdermal Patch Market
2.8 Key Manufacturers Transdermal Patch Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Transdermal Patch Status and Outlook by Region
3.1 Global Transdermal Patch Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Transdermal Patch Historic Market Size by Region
3.2.1 Global Transdermal Patch Sales in Volume by Region (2018-2023)
3.2.2 Global Transdermal Patch Sales in Value by Region (2018-2023)
3.2.3 Global Transdermal Patch Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Transdermal Patch Forecasted Market Size by Region
3.3.1 Global Transdermal Patch Sales in Volume by Region (2024-2029)
3.3.2 Global Transdermal Patch Sales in Value by Region (2024-2029)
3.3.3 Global Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Transdermal Patch by Application
4.1 Transdermal Patch Market Segment by Application
4.1.1 Rx Channel
4.1.2 OTC Channel
4.2 Global Transdermal Patch Market Size by Application
4.2.1 Global Transdermal Patch Market Size Overview by Application (2018-2029)
4.2.2 Global Transdermal Patch Historic Market Size Review by Application (2018-2023)
4.2.3 Global Transdermal Patch Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Patch Sales Breakdown by Application (2018-2023)
4.3.2 Europe Transdermal Patch Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Transdermal Patch Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Transdermal Patch Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Transdermal Patch Sales Breakdown by Application (2018-2023)
5 North America Transdermal Patch by Country
5.1 North America Transdermal Patch Historic Market Size by Country
5.1.1 North America Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Transdermal Patch Sales in Volume by Country (2018-2023)
5.1.3 North America Transdermal Patch Sales in Value by Country (2018-2023)
5.2 North America Transdermal Patch Forecasted Market Size by Country
5.2.1 North America Transdermal Patch Sales in Volume by Country (2024-2029)
5.2.2 North America Transdermal Patch Sales in Value by Country (2024-2029)
6 Europe Transdermal Patch by Country
6.1 Europe Transdermal Patch Historic Market Size by Country
6.1.1 Europe Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Transdermal Patch Sales in Volume by Country (2018-2023)
6.1.3 Europe Transdermal Patch Sales in Value by Country (2018-2023)
6.2 Europe Transdermal Patch Forecasted Market Size by Country
6.2.1 Europe Transdermal Patch Sales in Volume by Country (2024-2029)
6.2.2 Europe Transdermal Patch Sales in Value by Country (2024-2029)
7 Asia-Pacific Transdermal Patch by Region
7.1 Asia-Pacific Transdermal Patch Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Patch Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Transdermal Patch Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Transdermal Patch Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Transdermal Patch Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Patch Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Transdermal Patch Sales in Value by Region (2024-2029)
8 Latin America Transdermal Patch by Country
8.1 Latin America Transdermal Patch Historic Market Size by Country
8.1.1 Latin America Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Transdermal Patch Sales in Volume by Country (2018-2023)
8.1.3 Latin America Transdermal Patch Sales in Value by Country (2018-2023)
8.2 Latin America Transdermal Patch Forecasted Market Size by Country
8.2.1 Latin America Transdermal Patch Sales in Volume by Country (2024-2029)
8.2.2 Latin America Transdermal Patch Sales in Value by Country (2024-2029)
9 Middle East and Africa Transdermal Patch by Country
9.1 Middle East and Africa Transdermal Patch Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Transdermal Patch Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Transdermal Patch Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Transdermal Patch Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Patch Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Transdermal Patch Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Hisamitsu Pharmaceutical
10.1.1 Hisamitsu Pharmaceutical Company Information
10.1.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
10.1.5 Hisamitsu Pharmaceutical Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson Transdermal Patch Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Transdermal Patch Products Offered
10.3.5 Novartis Recent Development
10.4 UCB Pharma
10.4.1 UCB Pharma Company Information
10.4.2 UCB Pharma Introduction and Business Overview
10.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.4.4 UCB Pharma Transdermal Patch Products Offered
10.4.5 UCB Pharma Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Transdermal Patch Products Offered
10.5.5 Mylan Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Information
10.6.2 Teva Pharmaceutical Introduction and Business Overview
10.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Pharmaceutical Transdermal Patch Products Offered
10.6.5 Teva Pharmaceutical Recent Development
10.7 Nitto Denko
10.7.1 Nitto Denko Company Information
10.7.2 Nitto Denko Introduction and Business Overview
10.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Nitto Denko Transdermal Patch Products Offered
10.7.5 Nitto Denko Recent Development
10.8 Grünenthal
10.8.1 Grünenthal Company Information
10.8.2 Grünenthal Introduction and Business Overview
10.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Grünenthal Transdermal Patch Products Offered
10.8.5 Grünenthal Recent Development
10.9 IBSA Group
10.9.1 IBSA Group Company Information
10.9.2 IBSA Group Introduction and Business Overview
10.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.9.4 IBSA Group Transdermal Patch Products Offered
10.9.5 IBSA Group Recent Development
10.10 GSK
10.10.1 GSK Company Information
10.10.2 GSK Introduction and Business Overview
10.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.10.4 GSK Transdermal Patch Products Offered
10.10.5 GSK Recent Development
10.11 Luye Pharma Group
10.11.1 Luye Pharma Group Company Information
10.11.2 Luye Pharma Group Introduction and Business Overview
10.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Luye Pharma Group Transdermal Patch Products Offered
10.11.5 Luye Pharma Group Recent Development
10.12 Pfizer
10.12.1 Pfizer Company Information
10.12.2 Pfizer Introduction and Business Overview
10.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Pfizer Transdermal Patch Products Offered
10.12.5 Pfizer Recent Development
10.13 Chattem
10.13.1 Chattem Company Information
10.13.2 Chattem Introduction and Business Overview
10.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Chattem Transdermal Patch Products Offered
10.13.5 Chattem Recent Development
10.14 Dr Reddy’s Laboratories
10.14.1 Dr Reddy’s Laboratories Company Information
10.14.2 Dr Reddy’s Laboratories Introduction and Business Overview
10.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Dr Reddy’s Laboratories Transdermal Patch Products Offered
10.14.5 Dr Reddy’s Laboratories Recent Development
10.15 Bayer
10.15.1 Bayer Company Information
10.15.2 Bayer Introduction and Business Overview
10.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Bayer Transdermal Patch Products Offered
10.15.5 Bayer Recent Development
10.16 Mundipharma
10.16.1 Mundipharma Company Information
10.16.2 Mundipharma Introduction and Business Overview
10.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Mundipharma Transdermal Patch Products Offered
10.16.5 Mundipharma Recent Development
10.17 Endo International
10.17.1 Endo International Company Information
10.17.2 Endo International Introduction and Business Overview
10.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Endo International Transdermal Patch Products Offered
10.17.5 Endo International Recent Development
10.18 Beijing Tide Pharmaceutical
10.18.1 Beijing Tide Pharmaceutical Company Information
10.18.2 Beijing Tide Pharmaceutical Introduction and Business Overview
10.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
10.18.5 Beijing Tide Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Patch Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Patch Industrial Chain Analysis
11.4 Transdermal Patch Market Dynamics
11.4.1 Transdermal Patch Industry Trends
11.4.2 Transdermal Patch Market Drivers
11.4.3 Transdermal Patch Market Challenges
11.4.4 Transdermal Patch Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Patch Distributors
12.3 Transdermal Patch Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock